Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYALURONIDASE for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where HYALURONIDASE was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for HYALURONIDASE

Side Effect Reports % Deaths Hosp.
Fatigue 375 33.9% 241 342
Alopecia 358 32.3% 229 337
Abdominal discomfort 355 32.1% 253 345
Arthralgia 349 31.5% 223 317
Diarrhoea 330 29.8% 225 313
Headache 328 29.6% 238 312
Hypertension 325 29.4% 240 301
Blood cholesterol increased 320 28.9% 221 312
Arthropathy 318 28.7% 208 300
Off label use 315 28.5% 171 247
Condition aggravated 313 28.3% 210 293
Hypersensitivity 313 28.3% 203 263
Dyspnoea 304 27.5% 235 291
Type 2 diabetes mellitus 301 27.2% 236 294
Musculoskeletal stiffness 300 27.1% 214 283

Other Indications for HYALURONIDASE

Rheumatoid arthritis (348) Product used for unknown indication (293) Her2 positive breast cancer (69) Breast cancer metastatic (59) Local anaesthesia (24) Post procedural complication (21) Anaesthesia (18) Plasma cell myeloma (18) Adjuvant therapy (13) Blepharoplasty (11)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

HYALURONIDASE Full Profile All Relapsing-remitting multiple sclerosis Drugs HYALURONIDASE Demographics HYALURONIDASE Timeline